Safety and efficacy of INCA033989, a novel first in class mutant calreticulin-specific monoclonal antibody, in patients with essential thrombocythemia
Vikas Gupta(Princess Margaret Cancer Centre), Claire Harrison(Guy's and St Thomas' NHS Foundation Trust), Hiroki Yamaguchi(Nippon Medical School), Jean‐Jacques Kiladjian(Délégation Paris 5), Frank Stegelmann(University Hospital Ulm), Betty Lamothe(Incyte (United States)), Chi-Joan How(Brigham and Women's Hospital), Aaron T. Gerds(Cleveland Clinic), Tatiana Zinger(Incyte (United States)), Ruben A. Mesa(Atrium Health Wake Forest Baptist), Tania Jain(Sidney Kimmel Comprehensive Cancer Center), Yosuke Nakaya(Tokyo Metropolitan University), Andrew C. Perkins(Monash Medical Centre), David M. Ross(Flinders Medical Centre), Bethan Psaila(University of Oxford), Natasha Szuber(Hôpital Maisonneuve-Rosemont), Chenwei Tian(Incyte (United States)), Jason Gotlib(Stanford University), Haris Ali(City of Hope), Erin L. Crowgey(Nemours Children's Health System), Abdulraheem Yacoub(The University of Kansas Cancer Center), John Mascarenhas(Tisch Hospital), Makoto Yoshimitsu(Kagoshima University Hospital), Raajit K. Rampal(Memorial Sloan Kettering Cancer Center), Rosa Ayala(Hospital Universitario 12 De Octubre), William Shomali(Stanford Medicine), Jyoti Nangalia(Wellcome Sanger Institute), Evan Braunstein(Incyte (United States)), Caroline McNamara(University Health Network), Alessandro Maria Vannucchi(University of Florence), Lynette Chee(The Royal Melbourne Hospital), Francesca Palandri(Istituto Oncologico Romagnolo), Professor Francesco Passamonti(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Steffen Koschmieder(RWTH Aachen University)
Cited by 7
Related Papers
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Pre-metastatic niches: organ-specific homes for metastases
|Nature reviews. Cancer|2017|1.9k
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
|The Lancet|2020|1.8k
Somatic <i>CALR</i> Mutations in Myeloproliferative Neoplasms with Nonmutated <i>JAK2</i>
|New England Journal of Medicine|2013|1.7k